BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29694842)

  • 1. Baseline striatal and nigral interneuronal protein levels in two distinct mice strains differ in accordance with their MPTP susceptibility.
    Bhaduri B; Abhilash PL; Alladi PA
    J Chem Neuroanat; 2018 Sep; 91():46-54. PubMed ID: 29694842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
    Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
    Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent Expression Patterns of Drp1 and HSD10 in the Nigro-Striatum of Two Mice Strains Based on their MPTP Susceptibility.
    Seshadri A; Alladi PA
    Neurotox Res; 2019 Jul; 36(1):27-38. PubMed ID: 30993548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admixing MPTP-resistant and MPTP-vulnerable mice enhances striatal field potentials and calbindin-D28K expression to avert motor behaviour deficits.
    Vidyadhara DJ; Sasidharan A; Kutty BM; Raju TR; Alladi PA
    Behav Brain Res; 2019 Mar; 360():216-227. PubMed ID: 30529402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis.
    Tandé D; Höglinger G; Debeir T; Freundlieb N; Hirsch EC; François C
    Brain; 2006 May; 129(Pt 5):1194-200. PubMed ID: 16481374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDNF is predominantly expressed in the PV+ neostriatal interneuronal ensemble in normal mouse and after injury of the nigrostriatal pathway.
    Hidalgo-Figueroa M; Bonilla S; Gutiérrez F; Pascual A; López-Barneo J
    J Neurosci; 2012 Jan; 32(3):864-72. PubMed ID: 22262884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of calbindin in nigral dopaminergic neurons in two mice strains with differential susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Vidyadhara DJ; Yarreiphang H; Abhilash PL; Raju TR; Alladi PA
    J Chem Neuroanat; 2016 Oct; 76(Pt B):82-89. PubMed ID: 26775762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-binding protein, secretagogin, characterizes novel groups of interneurons in the rat striatum.
    Kosaka T; Yasuda S; Kosaka K
    Neurosci Res; 2017 Jun; 119():53-60. PubMed ID: 28193530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
    Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions.
    Petryszyn S; Parent A; Parent M
    J Neural Transm (Vienna); 2018 Mar; 125(3):279-290. PubMed ID: 28168621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
    Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey.
    Gerfen CR; Baimbridge KG; Miller JJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8780-4. PubMed ID: 3909155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic Factors and Mitochondrial Complexes Assist Determination of Strain-Specific Susceptibility of Mice to Parkinsonian Neurotoxin MPTP.
    Yarreiphang H; Vidyadhara DJ; Nambisan AK; Raju TR; Sagar BKC; Alladi PA
    Mol Neurobiol; 2023 Aug; 60(8):4778-4794. PubMed ID: 37162724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys.
    Petryszyn S; Di Paolo T; Parent A; Parent M
    Neurobiol Dis; 2016 Nov; 95():46-53. PubMed ID: 27388937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW; Son HY; Jin GZ; Park YK
    Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
    Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.